{
    "SPADE_N_15313": {
        "Sequence Information": {
            "Peptide Name": "Orbitide  [1−9-NαC]-Crourorb A1",
            "Sequence": "GSLGAFGNL",
            "Sequence Length": 9,
            "Biological Activity": [
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "1. Croton urucurana",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Cytotoxic Orbitide from the Latex of Croton urucurana.",
                    "Pubmed ID": "26561866",
                    "Reference": "J Nat Prod. 2015;78:2754-2760",
                    "Author": "Cândido-Bacani Pde M, Figueiredo Pde O, Matos Mde F, Garcez FR, Garcez WS",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/26561866"
                }
            ],
            "Mass": 834.92,
            "PI": 5.53,
            "Net Charge": 0,
            "Hydrophobicity": 0.74,
            "Frequent Amino Acids": "GLA",
            "Absent Amino Acids": "CDEHIKMOPQRTUVWY",
            "Basic Residues": 0,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 4,
            "Polar Residues": 5,
            "Positive Residues": 0,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_N_15313",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_01539",
                    "Similarity": 1.0,
                    "Sequence": "GLWSTIKNVGKEAAIAAGKAVLGSL"
                },
                {
                    "SPADE_ID": "SPADE_N_02614",
                    "Similarity": 1.0,
                    "Sequence": "FMPIIGRLMSGSL"
                },
                {
                    "SPADE_ID": "SPADE_UN_12651",
                    "Similarity": 1.0,
                    "Sequence": "ILGTILKLLGSL"
                }
            ],
            "Hemolytic Activity": "Mouse fibroblasts NIH 3T3:IC50=>305.8 µg/ml",
            "Target Organism": "Human kidney Adenocarcinoma 786-0(IC50=18.69±0.82µg/ml),Human colon adenocarcinoma HT29(IC50=37.28±0.57µg/ml),Human breast adenocarcinoma MCF-7(IC50=35.49±2.59µg/ml),Human ovarian cancer NCI/ADR-RES(IC50=3.98±0.20µg/ml),Human hepatocellular carcinoma HepG2(IC50=41.31±2.70µg/ml),Human prostate adenocarcinoma PC-3(IC50=29.80±0.34µg/ml)"
        }
    }
}